Dendritic cells in cancer therapy
Time: 2011, friday the 14th of January, 13.00
Place: Auditorium 54 N2C, Herlev University Hospital, Herlev Ringvej 75, DK-2730 Herlev
Agenda
13.00-13.10
Introduction
By: Inge Marie Svane, CCIT, Department of Hematology, Department of Oncology, Herlev University Hospital, Denmark
13.15-14.00
Title: The immunogenic potential of mRNA-transfected dendritic cells in breast cancer -
from bench to bedside
By: Özcan Met, CCIT, Department of Hematology, Department of Oncology, Herlev University Hospital, Denmark
14.00-14.45
Title: Melanoma immunotherapy, the Brussels' experience
By: Kris Thielemans, Medical School of the Vrije Universiteit Brussel, Brussels, Belgium
14.45-15.00
Coffe break
15.00-15.45
Title: Migration and effectiveness of tumor-antigen loaded dendritic cell in cancer patients
By: I. Jolanda M. de Vries, Department of Medical Oncology and Tumor Immunology, Nijmegen Centre for Molecular Life Sciences, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
15.45-16.30
Title: Melanoma patients treated with Dendritic cell vaccination, Interleukin-2 and
metronomic Cyclophosphamide - Results from a phase II trial
By: Eva Ellebęk, CCIT, Department of Hematology, Department of Oncology, Herlev University Hospital, Denmark
16.30-16.40
Discussion and closure
Download invitation and agenda: mini symposium january 14, 2010 , PDF, 62 kb
Last update: January 03, 2011
Disclaimer | Top